Insights from

Nobel Laureates, for scientists everywhere

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

Aaron Ciechanover

Brazil – São Paulo, Brasília and Rio de Janeiro

9th Aug – 11th Aug 2017

In August 2017, Nobel Laureate Aaron Ciechanover visited Brazil as part of the Nobel Prize Inspiration Initiative. He met with scientists at the following institutions in São Paulo, Brasília and Rio de Janeiro:

  • Universidade de São Paulo
  • Agência Nacional de Vigilância Sanitária (National Health Surveillance Agency, Anvisa)
  • Universidade de Brasília
  • Instituto Nacional de Câncer (INCA)
  • Fiocruz

See the photos from the event:

Watch the short highlights from the event (1 minute):

Watch the 3 minute highlights from the event:

Watch his on-stage interview at AstraZeneca Brazil:

Watch his lecture ‘Are We Going to Cure all Diseases and at What Price?’ at Universidade de São Paulo:

Aaron Ciechanover

Aaron Ciechanover

Aaron Ciechanover was born in Haifa, Israel in 1947. He is currently a Distinguished Research Professor in the Faculty of medicine at the Technion – Israel Institute of Technology in Haifa, Israel. He received his MSc (1971) and MD (1973) from the Hebrew University in Jerusalem. He then completed his national service (1973-1976) as military physician, and continued his studies to obtain a doctorate in biological sciences in the Faculty of Medicine in the Technion (DSc; 1982).

There, as a graduate student with Dr Avram Hershko and in collaboration with Dr. Irwin A. Rose from the Fox Chase Cancer Center in Philadelphia, USA, they discovered that covalent attachment of ubiquitin to a target protein signals it for degradation. They deciphered the mechanism of conjugation, described the general proteolytic functions of the system, and proposed a model according to which this modification serves as a recognition signal for a specific downstream protease.

As a post-doctoral fellow with Dr Harvey Lodish at the M.I.T., he continued his studies on the ubiquitin system and made additional important discoveries. Along the years it has become clear that ubiquitin-mediated proteolysis plays major roles in numerous cellular processes, and aberrations in the system underlie the pathogenetic mechanisms of many diseases, among them certain malignancies and neurodegenerative disorders. Consequently, the system has become an important platform for drug development.

Among the numerous prizes Ciechanover received are the 2000 Albert Lasker Award, the 2003 Israel Prize, and the 2004 Nobel Prize (Chemistry; shared with Drs Hershko and Rose).